Jack Geltosky
Director/Board Member bij MEDICENNA THERAPEUTICS CORP.
Vermogen: - $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Jack Geltosky
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
26
| Extinct | Pharmaceuticals: Major | 26 |
| Public Company | Biotechnology | 18 | |
Aztec Components, Inc.
 Aztec Components, Inc. Electronics DistributorsDistribution Services Aztec Components, Inc. distributes electronic components, semiconductors and peripherals. It supplies passive and peripheral components. The company was founded in 1996 and is headquartered in Vista, CA.
3
| Private Company | Electronics Distributors | 3 |
| Public Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jack Geltosky via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Corporate Officer/Principal Private Equity Investor Private Equity Analyst | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| SERNOVA CORP. | Biotechnology | Director of Finance/CFO Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Investment Managers | Director/Board Member Founder Private Equity Investor | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Icahn Capital LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Sarissa Capital Management LP
 Sarissa Capital Management LP Investment ManagersFinance Sarissa Capital Management LP (Sarissa) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2012 by Alexander Denner and Mayuran Sriskandarajah. Sarissa provides investment advisory services to pooled investment vehicles operating as private investment funds. | Investment Managers | Chief Executive Officer Founder | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Chief Investment Officer Chief Investment Officer | |
ReSearch Pharmaceutical Services LLC
 ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Masters Business Admin | |
| University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Western Ontario | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chairman | |
PheroTech International, Inc.
 PheroTech International, Inc. Chemicals: AgriculturalProcess Industries Pherotech International was founded in 1980 and is a Canadian-based revenue producing Life Science company that is a world leader in the development and commercialization of semiochemical and non-toxic insect trapping technologies for pest management in home and garden, forestry, agricultural, structural and commercial applications. Since Pherotech was founded, it has assembled a world-class team of business executives and scientific advisors. Pherotech International offers a wide variety of scientifically-backed leading products with an established distribution network as well as direct sales to large customers that include the U.S. Department of Agriculture, the Canadian Forest Service and large retail chains such as Wal-Mart. The company has an impressive pipeline of new products with strong commercial potential that will allow it to grow profitably and maximize its returns on invested capital for years to come. | Chemicals: Agricultural | Chairman Director/Board Member | |
Lions Capital Corp.
 Lions Capital Corp. Investment ManagersFinance Lions Capital Corp (Lions Capital) is a fund management and corporate advisory firm founded in 2003. The firm headquartered in Vancouver, Canada. | Investment Managers | President Chief Executive Officer | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Alita Pharmaceuticals, Inc.
 Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| EMERALD HEALTH THERAPEUTICS | Agricultural Commodities/Milling | Chief Executive Officer Chairman | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman President | |
Medicenna Therapeutics, Inc.
 Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Founder Director/Board Member | |
Emerald Health Sciences, Inc.
 Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Sciences, Inc. develops cannabinoid pharmaceutical drugs. It targets botanicals including medical & recreational and nutraceutical segments. The company was founded on July 31 2007is headquartered in Victoria, Canada. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Emerald Health Pharmaceuticals, Inc.
 Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Chairman | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Biotechnology | Chairman Director/Board Member | |
Verdélite Sciences, Inc.
 Verdélite Sciences, Inc. Pharmaceuticals: OtherHealth Technology Verdélite Sciences, Inc. produces medical marijuana. The company is headquartered in Saint-Eustache, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Verdélite Property Holdings, Inc.
 Verdélite Property Holdings, Inc. Agricultural Commodities/MillingProcess Industries Verdélite Property Holdings, Inc. operates as an investment holding company. The company is headquartered in Laval, Canada. | Agricultural Commodities/Milling | Chairman Director/Board Member | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 31 |
| Canada | 18 |
| Ierland | 2 |
| Denemarken | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 29 |
| Finance | 8 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Process Industries | 5 |
Operationeel
| Director/Board Member | 313 |
| Independent Dir/Board Member | 102 |
| Corporate Officer/Principal | 95 |
| Chairman | 66 |
| President | 48 |
Sterkste connecties
| Insiders | |
|---|---|
| Nitin Kaushal | 51 |
| Jonathan Leff | 45 |
| Noah Knauf | 35 |
| Frank Holler | 29 |
| Avtar Dhillon | 25 |
| Alexander Denner | 25 |
| James Heppell | 24 |
| Joseph Turner | 22 |
| Chandrakant Panchal | 22 |
| Karen Dawes | 21 |
| Lars Ekman | 21 |
| Jim J. Miller | 19 |
| Alexander R. Giaquinto | 19 |
| Gerry Proehl | 19 |
| Richard Mulligan | 19 |
- Beurs
- Insiders
- Jack Geltosky
- Bedrijfsconnecties
